리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 07월
페이지 정보:영문 467 Pages
라이선스 & 가격 (부가세 별도)
한글목차
디지털 심리요법 세계 시장은 2030년까지 40억 달러에 달할 전망
2024년에 16억 달러로 추정되는 디지털 심리요법 세계 시장은 분석 기간인 2024-2030년에 CAGR 16.8%로 성장하여 2030년에는 40억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 단독요법 솔루션은 CAGR 18.2%를 기록하며 분석 기간 종료시에는 30억 달러에 달할 것으로 예측됩니다. 병용요법 솔루션 부문의 성장률은 분석 기간 동안 CAGR 13.6%로 추정됩니다.
미국 시장은 4억 3,350만 달러로 추정, 중국은 CAGR 22.4%로 성장 예측
미국의 디지털 심리요법 시장은 2024년에 4억 3,350만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 8억 9,960만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 22.4%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 12.3%와 15.2%로 예측됩니다. 유럽에서는 독일이 CAGR 약 13.4%로 성장할 것으로 예측됩니다.
세계 디지털 심리요법 시장 - 주요 동향 및 촉진요인 정리
디지털 심리요법이 정신건강 관리의 공백을 메울 수 있을까?
디지털 심리요법의 부상은 디지털 플랫폼을 통해 확장 가능하고 증거에 기반한 치료 개입을 제공함으로써 정신건강 관리에 변화를 가져오고 있습니다. 전 세계적으로 정신건강 질환이 증가하는 가운데, 전통적인 대면 치료 서비스는 정신건강 전문가 부족과 접근성 장벽으로 인해 수요를 충족시키는 데 어려움을 겪고 있습니다. 정신건강을 위한 디지털 치료(DTx)로도 알려진 디지털 심리요법은 인공지능(AI), 인지행동치료(CBT), 모바일 기반 개입을 활용하여 불안, 우울증, PTSD, 불면증 등의 증상에 대해 임상적으로 검증된 치료를 제공합니다. Wobot, SilverCloud, Wysa 등의 앱은 AI 기반 챗봇을 통해 실시간 정서적 지원과 가이드 치료 프로그램을 제공함으로써 정신보건 서비스를 충분히 받지 못하는 사람들에게도 정신건강 관리를 보다 쉽게 접근할 수 있도록 하고 있습니다. 또한, 원격 치료 플랫폼은 디지털 심리 치료와 치료사의 실시간 지원을 통합하여 치료의 순응도와 효과를 높이고 있습니다. 그러나 규제 문제, 환자 데이터 프라이버시 문제, 장기적인 임상 검증의 필요성 등이 보급의 주요 장벽으로 작용하고 있습니다. 이러한 어려움에도 불구하고, 디지털 심리요법은 개인화되고 비용 효율적인 치료 개입을 제공함으로써 전 세계 정신건강 관리의 격차를 해소할 수 있는 중요한 솔루션으로 부상하고 있습니다.
AI와 머신러닝은 디지털 치료를 어떻게 강화할 수 있을까?
인공지능(AI)과 머신러닝(ML)은 디지털 심리요법에서 개인화된 치료 추천, 실시간 기분 추적, 적응형 치료 모듈을 가능하게 하는 등 혁신적인 역할을 하고 있습니다. 패턴, 웨어러블 기기의 생체 데이터를 분석하여 정서적 고통의 초기 징후를 감지하고 적절한 개입을 추천합니다. 예측 분석 모델은 치료의 진행 상황을 평가하고, 임상의가 개인별 반응에 따라 치료 계획을 개선할 수 있도록 돕습니다. 또한 자연어 처리(NLP) 알고리즘을 통해 AI 기반 챗봇은 치료 대화를 시뮬레이션하고 사용자에게 즉각적인 심리적 지원을 제공할 수 있습니다. 그러나 AI를 활용한 디지털 치료 솔루션이 큰 이점을 제공하는 반면, 알고리즘의 편향성, 오진 위험, 데이터 보안에 대한 우려는 여전히 해결해야 할 과제로 남아 있으며, AI 기술이 계속 발전함에 따라 심리 치료와의 통합을 통해 치료의 개인화, 치료 순응도, 치료 순응도, 치료 순응도, 치료 효과, 치료 효과, 치료 효과, 치료 효과, 치료 효과, 치료 효과, 치료 효과, 치료 효과, 치료 효과, 치료 효과 치료의 개별화, 순응도, 정신건강 관리의 조기 개입 전략의 개선이 기대됩니다.
가상현실(VR)과 게임화가 정신건강의 결과를 개선할 수 있을까?
가상현실(VR)과 게임화는 디지털 심리요법의 혁신적인 도구로 부상하고 있으며, VR을 이용한 노출치료는 불안장애, 공포증, PTSD를 치료하는 데 활용되고 있습니다. 두려움에 직면하고 대처할 수 있도록 통제된 시뮬레이션 환경에 몰입할 수 있도록 되어 있습니다. 보상 시스템이나 인터랙티브 운동과 같은 게임화 요소는 정신건강 개입을 보다 매력적으로 만들어 치료 순응도를 높이고 있으며, SuperBetter나 MindEase와 같은 앱은 게임 기반 메커니즘을 통해 긍정적인 행동 변화와 회복을 유도하고 있습니다. 긍정적인 행동 변화와 회복탄력성을 향상시키는 연습을 장려하고 있습니다. 또한, 바이오피드백과 통합된 VR 치료는 실시간 스트레스 모니터링을 가능하게 하고, 마음챙김 기술을 통해 사용자의 정서적 반응을 조절하는 데 도움을 주고 있습니다. 이러한 잠재적 이점에도 불구하고, 가격, 접근성, 특수 하드웨어의 필요성과 같은 문제는 여전히 도입의 장벽으로 작용하고 있습니다. 그러나 VR과 게임화 기술의 발전은 디지털 심리요법에 혁명을 불러일으키고, 정신건강 치료를 보다 몰입감 있고 효과적으로 만들 수 있을 것으로 기대되고 있습니다.
디지털 심리요법 시장의 성장 원동력은?
디지털 심리 치료 시장의 성장은 정신건강 장애의 유병률 증가, 정신건강 전문가 부족, AI 기반 치료 솔루션의 수용 확대 등 여러 요인에 의해 이루어지고 있습니다. 모바일 헬스(mHealth) 애플리케이션과 웨어러블 기술의 발전으로 실시간 정신건강 추적 및 개입이 가능해졌습니다. 디지털 치료제에 대한 규제적 지원과 디지털 정신건강 솔루션에 대한 상환 정책의 증가로 인해 디지털 치료제의 채택이 더욱 가속화되고 있습니다. 원격의료와 가상 치료 세션의 인기가 높아지면서 디지털 심리요법이 정신건강 관리의 주류로 편입되고 있습니다. 또한, 정신건강 및 기업 정신건강 프로그램에 대한 관심이 높아짐에 따라 확장 가능한 디지털 우선 솔루션에 대한 수요가 증가하고 있습니다. 기술이 발전함에 따라 디지털 심리요법은 치료를 보다 친숙하고, 데이터 기반이며, 개인화할 수 있게함으로써 정신건강의 미래에 중요한 역할을 할 것으로 기대됩니다.
부문
솔루션(단독요법 솔루션, 병용요법 솔루션), 적응증(공포증·불안장애 적응증, 정신병성 장애 적응증, 기타 적응증), 비즈니스 모델(환자·소비자 직판 비즈니스 모델, 기업간 비즈니스 모델), 용도(예방 용도, 관리 용도, 치료 용도)
조사 대상 기업 사례
2Morrow
Big Health
BetterHelp
Cara Care
Click Therapeutics
Dialogue Health Technologies
Happify Health
Headspace
HelloBetter
Limbic
Livongo Health
Modern Health
Noom
Pear Therapeutics
Rejoyn
SilverCloud Health
Talkspace
Tata Elxsi
Teladoc Health
Woebot Health
AI 통합
Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
ksm
영문 목차
영문목차
Global Digital Psychotherapeutics Market to Reach US$4.0 Billion by 2030
The global market for Digital Psychotherapeutics estimated at US$1.6 Billion in the year 2024, is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 16.8% over the analysis period 2024-2030. Monotherapy Solution, one of the segments analyzed in the report, is expected to record a 18.2% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Combination Therapy Solution segment is estimated at 13.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$433.5 Million While China is Forecast to Grow at 22.4% CAGR
The Digital Psychotherapeutics market in the U.S. is estimated at US$433.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$899.6 Million by the year 2030 trailing a CAGR of 22.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.3% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.
Global Digital Psychotherapeutics Market - Key Trends & Drivers Summarized
Can Digital Psychotherapeutics Bridge the Mental Healthcare Gap?
The rise of digital psychotherapeutics is transforming mental healthcare by providing scalable, evidence-based therapeutic interventions through digital platforms. With global mental health disorders on the rise, traditional in-person therapy services are struggling to meet demand due to shortages of mental health professionals and accessibility barriers. Digital psychotherapeutics, also known as digital therapeutics (DTx) for mental health, leverage artificial intelligence (AI), cognitive behavioral therapy (CBT), and mobile-based interventions to provide clinically validated treatments for conditions such as anxiety, depression, PTSD, and insomnia. Apps such as Woebot, SilverCloud, and Wysa use AI-driven chatbots to offer real-time emotional support and guided therapy programs, making mental healthcare more accessible to underserved populations. Additionally, teletherapy platforms integrate digital psychotherapeutics with live therapist support, enhancing treatment adherence and effectiveness. However, regulatory challenges, concerns over patient data privacy, and the need for long-term clinical validation remain key barriers to widespread adoption. Despite these challenges, digital psychotherapeutics are emerging as a critical solution to bridge the global mental healthcare gap, offering personalized and cost-effective therapeutic interventions.
How Are AI and Machine Learning Enhancing Digital Therapy?
Artificial intelligence (AI) and machine learning (ML) are playing a transformative role in digital psychotherapeutics, enabling personalized treatment recommendations, real-time mood tracking, and adaptive therapy modules. AI-powered mental health platforms analyze user behavior, speech patterns, and biometric data from wearable devices to detect early signs of emotional distress and recommend appropriate interventions. Predictive analytics models assess therapy progress, helping clinicians refine treatment plans based on individual responses. Additionally, natural language processing (NLP) algorithms enable AI-driven chatbots to simulate therapeutic conversations, providing users with immediate psychological support. However, while AI-driven digital therapy solutions offer significant benefits, concerns regarding algorithm bias, misdiagnosis risks, and data security remain challenges that need to be addressed. As AI technology continues to evolve, its integration with psychotherapeutics is expected to improve treatment personalization, adherence rates, and early intervention strategies in mental healthcare.
Can Virtual Reality (VR) and Gamification Improve Mental Health Outcomes?
Virtual reality (VR) and gamification are emerging as innovative tools in digital psychotherapeutics, enhancing user engagement and therapy effectiveness. VR-based exposure therapy is being used to treat anxiety disorders, phobias, and PTSD by immersing patients in controlled, simulated environments that help them confront and manage their fears. Gamification elements, such as reward systems and interactive exercises, are improving therapy adherence by making mental health interventions more engaging. Apps like SuperBetter and MindEase use game-based mechanics to encourage positive behavioral changes and resilience-building exercises. Additionally, biofeedback-integrated VR therapy is enabling real-time stress monitoring, helping users regulate their emotional responses through mindfulness techniques. Despite the potential benefits, challenges such as affordability, accessibility, and the need for specialized hardware remain barriers to adoption. However, as VR and gamification technologies advance, they are expected to revolutionize digital psychotherapeutics, making mental health treatment more immersive and effective.
What Is Driving the Growth of the Digital Psychotherapeutics Market?
The growth in the digital psychotherapeutics market is driven by several factors, including the increasing prevalence of mental health disorders, the shortage of mental health professionals, and the growing acceptance of AI-driven therapy solutions. Advancements in mobile health (mHealth) applications and wearable technology are enabling real-time mental health tracking and intervention. Regulatory support for digital therapeutics and increasing reimbursement policies for digital mental health solutions are further accelerating adoption. The rising popularity of telehealth and virtual therapy sessions is also integrating digital psychotherapeutics into mainstream mental healthcare. Additionally, the growing emphasis on mental wellness and corporate mental health programs is driving demand for scalable, digital-first solutions. As technology continues to improve, digital psychotherapeutics are expected to play a crucial role in the future of mental healthcare, making therapy more accessible, data-driven, and personalized.
SCOPE OF STUDY:
The report analyzes the Digital Psychotherapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Solution (Monotherapy Solution, Combination Therapy Solution); Indication (Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication, Other Indications); Business Model (Direct-To-Patients / Consumers Business Model, Business-to-Business Business Model); Application (Prevention Application, Management Application, Treatment Application)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 44 Featured) -
2Morrow
Big Health
BetterHelp
Cara Care
Click Therapeutics
Dialogue Health Technologies
Happify Health
Headspace
HelloBetter
Limbic
Livongo Health
Modern Health
Noom
Pear Therapeutics
Rejoyn
SilverCloud Health
Talkspace
Tata Elxsi
Teladoc Health
Woebot Health
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Digital Psychotherapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Prevalence of Mental Health Disorders Drives Demand for Digital Psychotherapeutics Solutions
Surge in Consumer Adoption of Digital Health Platforms Expands Addressable Market for Digital Psychotherapeutic Tools
Technological Advancements in Artificial Intelligence and Machine Learning Enhance the Effectiveness of Digital Psychotherapeutics
Rising Demand for Personalized and Accessible Mental Health Solutions Strengthens the Business Case for Digital Psychotherapeutics
Increased Focus on Mental Health and Wellbeing by Governments and Healthcare Providers Accelerates the Adoption of Digital Psychotherapeutics
The Growth of Remote and Telehealth Services Expands Opportunities for Digital Psychotherapeutics in Virtual Care Settings
The Rise of Wearable Devices and Mobile Applications for Mental Health Management Drives Growth in Digital Psychotherapeutics Solutions
Expansion of Regulatory Support for Digital Therapeutics Propels Adoption of Digital Psychotherapeutics in Mainstream Healthcare
The Growing Role of Behavioral Health in Overall Wellness Programs Expands the Reach of Digital Psychotherapeutics to Broader Audiences
Increasing Public and Corporate Investment in Mental Health Technology Drives Market Opportunities for Digital Psychotherapeutics Solutions
The Shift Toward Preventive Healthcare and Early Intervention Drives Adoption of Digital Psychotherapeutics for Mental Wellness
Rising Awareness of the Benefits of Digital Health and Self-Help Solutions Strengthens Market Demand for Digital Psychotherapeutics Platforms
The Emergence of Cognitive Behavioral Therapy (CBT) and Other Evidence-Based Techniques in Digital Form Drives Growth in Digital Psychotherapeutics
Integration of Digital Psychotherapeutics with Traditional Mental Health Services Expands Adoption Among Therapists and Psychologists
The Growth of Digital Therapeutics in the Treatment of Chronic Conditions, such as Depression and Anxiety, Expands Opportunities in Digital Psychotherapeutics
Increased Focus on Data Privacy and Security in Digital Health Solutions Drives Consumer Confidence and Adoption of Digital Psychotherapeutics
The Need for Scalable and Cost-Effective Mental Health Solutions in Resource-Constrained Environments Accelerates the Use of Digital Psychotherapeutics
Rising Popularity of Personalized Mental Health Programs, Powered by Data and AI, Expands Addressable Market for Digital Psychotherapeutics
The Integration of Gamification and Interactive Features in Digital Psychotherapeutics Solutions Enhances Patient Engagement and Retention
The Expansion of Digital Psychotherapeutics Across International Markets Creates Global Market Opportunities for Mental Health Solutions
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Digital Psychotherapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Digital Psychotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Monotherapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Monotherapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Monotherapy Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Combination Therapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Combination Therapy Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Combination Therapy Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Treatment Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Prevention Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Prevention Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Prevention Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Phobias & Anxiety Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Phobias & Anxiety Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Phobias & Anxiety Disorders Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Psychotic Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Psychotic Disorders Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Psychotic Disorders Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Direct-To-Patients / Consumers Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Direct-To-Patients / Consumers Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Direct-To-Patients / Consumers Business Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Business-to-Business Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Business-to-Business Business Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Business-to-Business Business Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: USA Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: USA 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: USA 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: USA 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Canada 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Canada 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
JAPAN
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 59: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Japan 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Japan 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 65: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
CHINA
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 71: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: China Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: China 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 74: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: China Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: China 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: China Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: China 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
EUROPE
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 83: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Digital Psychotherapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Europe 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Europe 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 95: Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Europe Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Europe 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
FRANCE
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 98: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: France Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: France 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 101: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: France Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: France 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 104: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: France Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: France 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 107: France Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: France Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 109: France 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
GERMANY
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 110: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: Germany Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 112: Germany 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 113: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 114: Germany Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 115: Germany 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 116: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: Germany Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 118: Germany 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 119: Germany Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 120: Germany Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 121: Germany 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
ITALY
TABLE 122: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: Italy Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 124: Italy 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 125: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 126: Italy Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 127: Italy 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 128: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Italy Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 130: Italy 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 131: Italy Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 132: Italy Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 133: Italy 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
UNITED KINGDOM
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 134: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: UK Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 136: UK 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 137: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 138: UK Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 139: UK 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 140: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: UK Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 142: UK 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 143: UK Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 144: UK Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 145: UK 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
SPAIN
TABLE 146: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 147: Spain Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 148: Spain 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 149: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 150: Spain Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 151: Spain 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 152: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: Spain Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 154: Spain 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 155: Spain Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 156: Spain Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 157: Spain 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
RUSSIA
TABLE 158: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: Russia Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 160: Russia 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 161: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 162: Russia Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 163: Russia 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 164: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 165: Russia Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 166: Russia 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 167: Russia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 168: Russia Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 169: Russia 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: Rest of Europe Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 172: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 174: Rest of Europe Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 175: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 177: Rest of Europe Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 178: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 180: Rest of Europe Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 181: Rest of Europe 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 183: Asia-Pacific Historic Review for Digital Psychotherapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 184: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 186: Asia-Pacific Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 187: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 189: Asia-Pacific Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 190: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 192: Asia-Pacific Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 193: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 195: Asia-Pacific Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 196: Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
AUSTRALIA
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 197: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 198: Australia Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 199: Australia 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 200: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 201: Australia Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 202: Australia 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 203: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 204: Australia Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 205: Australia 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 206: Australia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 207: Australia Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 208: Australia 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
INDIA
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 209: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 210: India Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 211: India 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 212: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 213: India Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 214: India 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 215: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 216: India Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 217: India 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 218: India Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 219: India Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 220: India 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 221: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 222: South Korea Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 223: South Korea 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 224: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 225: South Korea Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 226: South Korea 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 227: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 228: South Korea Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 229: South Korea 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 230: South Korea Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 231: South Korea Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 232: South Korea 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 234: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 237: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 240: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 243: Rest of Asia-Pacific Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
LATIN AMERICA
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 245: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 246: Latin America Historic Review for Digital Psychotherapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 247: Latin America 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 248: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 249: Latin America Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 250: Latin America 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 251: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 252: Latin America Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 253: Latin America 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 254: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 255: Latin America Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 256: Latin America 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 257: Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 258: Latin America Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 259: Latin America 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 260: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 261: Argentina Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 262: Argentina 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 263: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 264: Argentina Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 265: Argentina 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 266: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 267: Argentina Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 268: Argentina 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 269: Argentina Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 270: Argentina Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 271: Argentina 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
BRAZIL
TABLE 272: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 273: Brazil Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 274: Brazil 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 275: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 276: Brazil Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 277: Brazil 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 278: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 279: Brazil Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 280: Brazil 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 281: Brazil Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 282: Brazil Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 283: Brazil 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
MEXICO
TABLE 284: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 285: Mexico Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 286: Mexico 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 287: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 288: Mexico Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 289: Mexico 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 290: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 291: Mexico Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 292: Mexico 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 293: Mexico Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 294: Mexico Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 295: Mexico 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 297: Rest of Latin America Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 298: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 300: Rest of Latin America Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 301: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 303: Rest of Latin America Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 304: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 306: Rest of Latin America Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 307: Rest of Latin America 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
MIDDLE EAST
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 308: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 309: Middle East Historic Review for Digital Psychotherapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 310: Middle East 15-Year Perspective for Digital Psychotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 311: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 312: Middle East Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 313: Middle East 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 314: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 315: Middle East Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 316: Middle East 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 317: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 318: Middle East Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 319: Middle East 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 320: Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 321: Middle East Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 322: Middle East 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
IRAN
TABLE 323: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 324: Iran Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 325: Iran 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 326: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 327: Iran Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 328: Iran 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 329: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 330: Iran Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 331: Iran 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 332: Iran Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 333: Iran Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 334: Iran 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
ISRAEL
TABLE 335: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 336: Israel Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 337: Israel 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 338: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 339: Israel Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 340: Israel 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 341: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 342: Israel Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 343: Israel 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 344: Israel Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 345: Israel Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 346: Israel 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 348: Saudi Arabia Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 349: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 351: Saudi Arabia Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 352: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 354: Saudi Arabia Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 355: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 357: Saudi Arabia Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 358: Saudi Arabia 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 359: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 360: UAE Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 361: UAE 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 362: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 363: UAE Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 364: UAE 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 365: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 366: UAE Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 367: UAE 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 368: UAE Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 369: UAE Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 370: UAE 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 372: Rest of Middle East Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 373: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 375: Rest of Middle East Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 376: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 378: Rest of Middle East Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 379: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 381: Rest of Middle East Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 382: Rest of Middle East 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030
AFRICA
Digital Psychotherapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 383: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 384: Africa Historic Review for Digital Psychotherapeutics by Solution - Monotherapy Solution and Combination Therapy Solution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 385: Africa 15-Year Perspective for Digital Psychotherapeutics by Solution - Percentage Breakdown of Value Sales for Monotherapy Solution and Combination Therapy Solution for the Years 2015, 2025 & 2030
TABLE 386: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 387: Africa Historic Review for Digital Psychotherapeutics by Application - Treatment Application, Prevention Application and Management Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 388: Africa 15-Year Perspective for Digital Psychotherapeutics by Application - Percentage Breakdown of Value Sales for Treatment Application, Prevention Application and Management Application for the Years 2015, 2025 & 2030
TABLE 389: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 390: Africa Historic Review for Digital Psychotherapeutics by Indication - Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 391: Africa 15-Year Perspective for Digital Psychotherapeutics by Indication - Percentage Breakdown of Value Sales for Phobias & Anxiety Disorders Indication, Psychotic Disorders Indication and Other Indications for the Years 2015, 2025 & 2030
TABLE 392: Africa Recent Past, Current & Future Analysis for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 393: Africa Historic Review for Digital Psychotherapeutics by Business Model - Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 394: Africa 15-Year Perspective for Digital Psychotherapeutics by Business Model - Percentage Breakdown of Value Sales for Direct-To-Patients / Consumers Business Model and Business-to-Business Business Model for the Years 2015, 2025 & 2030